Jushi Holdings (JUSHF) Net Equity Issued and Repurchased (2022)
Jushi Holdings (JUSHF) posted quarterly Net Equity Issued and Repurchased of $13.7 million for Q1 2022.
Jushi Holdings (JUSHF) Net Equity Issued and Repurchased (2022) Analysis & Trends
Jushi Holdings (JUSHF) has reported Net Equity Issued and Repurchased for 1 consecutive years, with $13.7 million the latest figure, recorded in Q1 2022.
- In Q1 2022, Net Equity Issued and Repurchased changed N/A year-over-year to $13.7 million; the TTM figure through Dec 2022 stood at $13.7 million (changed N/A YoY), while the FY2022 annual figure was $13.7 million, down 84.03% from the prior year.
- Net Equity Issued and Repurchased steadied at $13.7 million in Q1 2022 per JUSHF's latest filing.
- Across five years, Net Equity Issued and Repurchased topped out at $13.7 million in Q1 2022 and bottomed at $13.7 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 13.68 Mn |
| Mar 31, 2022 | 13.68 Mn |